[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100453771":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":37,"responsibleParty":57,"collaborators":31,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":31,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":31,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":31,"overallStatus":40,"whyStopped":31,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"First Affiliated Hospital of Fujian Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"68Ga-Pentixafor","EXPERIMENTAL","Each subject receive a single intravenous injection of 68Ga-Pentixafor, and undergo PET\u002FCT imaging within the specificed time",[13],"Diagnostic Test: 68Ga-Pentixafor",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Each patient receive a single intravenous injection of 68Ga-Pentixafor, and undergo PET\u002FCT scan within specified time.",[9],[20],"PET\u002FCT scan",[22],{"name":23,"affiliation":24,"role":25},"Liangdi Xie, MD","the First Affiliated Hospital, Fujian Medical University","STUDY_CHAIR",[27,33],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Weibing Miao, MD","CONTACT","86-0591-87981618",null,"miaoweibing@126.com",{"name":34,"role":29,"phone":35,"phoneExt":31,"email":36},"Jinxiu Lin, MD","86-13799777113","linjinxiu@aliyun.com",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University","RECRUITING","Fuzhou","Fujian","350005","China","CN",{"type":47,"coordinates":48},"Point",[49,50],119.30611,26.06139,{"lat":50,"lon":49},[53,55],{"name":28,"role":29,"phone":54,"phoneExt":31,"email":32},"059187981618",{"name":34,"role":29,"phone":56,"phoneExt":31,"email":36},"86-13799977713",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"PRINCIPAL_INVESTIGATOR","Weibing Miao, PhD","Director, Department of Nuclear Medicine","100453771","application-of-68ga-pentixafor-petct-in-primary-aldosteronism-and-pre-postoperative-of-saae-100453771",false,"NCT05188872","Application of 68Ga-Pentixafor PET\u002FCT in Primary Aldosteronism and Pre-postoperative of SAAE","68Ga-Pentixafor PET\u002FCT in the Diagnosis of Primary Aldosteronism and Pre-postoperative of Superselective Adrenal Artery Embolization","Inclusion Criteria:\n\n* adult population (aged 18 years or order);\n* patients with suspected or new diagnosed Primary aldosteronism (supporting evidence may include MRI, CT, laboratory tests);\n* patients who had scheduled 68Ga-BNU-PSMA PET\u002FCT scan;\n* patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee;\n* healthy volunteers(aged 18 years or order).\n\nExclusion Criteria:\n\n* patients with pregnancy;\n* the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.","ALL","19 Years","90 Years",{"count":72,"type":73},100,"ESTIMATED","INTERVENTIONAL",[76],"NA","Primary aldosteronism is the most common cause of secondary hypertension. The two main types of primary aldosteronism are aldosteronoma(30%) and adrenal hyperplasia(60%). The gold standard that determines the diagnosis and treatment strategy of primary aldosteronism is adrenal vein sampling(AVS), but the success rate is only about 80%. Using CXCR4 as a probe for 68Ga-Pentixafor PET\u002FCT imaging can guide the classification diagnosis and treatment strategy of primary aldosteronism, which is a favorable supplement to AVS. Superselective adrenal artery embolization(SAAE) and laparoscopy are the main operation treatments for primary aldosteronism. SAAE is an invasive interventional operation. It is a novel way to evaluate the changes in the structure and function of adrenal tissue pre-postoperative SAAE by using the changes in 68Ga-Pentixafor PET\u002FCT imaging.",[79],"Positron-Emission Tomography","2026-07-19",{"date":82,"type":83},"2026-07-21","ACTUAL",{"date":85,"type":83},"2020-09-01",{"date":87,"type":73},"2027-09-01",{"name":5,"class":6},1]